Ocular signs and local treatment in myasthenia gravis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001763:Blepharoptosis / Q000209:etiology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004172:Diplopia / Q000209:etiology; D005132:Eye Manifestations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D009823:Ointment Bases; D009886:Ophthalmoplegia / Q000209:etiology
D002800:Cholinesterase Inhibitors; D009823:Ointment Bases